chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Skin rash; swelling of lymph nodes in left armpit (same arm where the injection was received); This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 01May2021 at 16:30(at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not received any concomitant medication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 12:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021, the patient experienced skin rash and swelling of lymph nodes in left armpit (same arm where the injection was received by patient). The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events skin rash and swelling of lymph nodes in left armpit was not recovered.  No follow-up attempts are needed. No further information is expected.
9-10 Sudden onset headache, chills, fever 101; 9-11 Fever 100.2, extreme fatigue; 9-12 Fever 100.2. Clinic visit. Started antibiotics. 9-13 Much better. Pt also reports hot, red left arm from shoulder to elbow from 9-9 to 9-15.
pt recv vax & devel a sterile abscess @ the inj site;the abscess was surgically removed;this is 1 of 2 pt from this facility to devel a sterile abscess @ the inj site p/vax;
Vaccine received Mon 10/02/06 started through the night with fever 103 and feeling of malaise. Pts treated with Ibuprofen 400 mg went to school Pm 10/03/06 states fells bad 10:00 Ibuprofen 400 mg 10/04/06 feels much better. Felt headache, nausea over week, mothers shares also reacted as an infant.
My left shoulder area was very sore with any movement.  I couldn?t even dress without it hurting.  I first started tried to rest my arm and take Tylenol and Motrin.  I went to the Orthopedic office and the doctor assessed it and tried some exercises and she diagnosed it with peritis and tendonitis.  I also did therapy, and they think I have a frozen shoulder.  I have a follow up in a few weeks for an MRI.
Patient received Covid vaccine Moderna at 11:30 A.M. patient was monitored inside clinic for 30 min due to previous allergies. After her 30 min was up she stated she felt fine and left the observation station. Patient walked outside of building and noticed she was having chest heaviness and started to have trouble breathing. Patient went back into Health department to notify of her status. Safety manager immediately notified nursing. This was at 12:05. Public Health Nurse  assessed patient and had her take two Benadryl b/p 190/90  , Rep slow at 12 AP 47 Patient stated difficulty breathing. Nurse stated epi was needed Epi 0.3 auto injector given at 12:07. 911 notified by phone. Within a min patient stated she could breath better. Emergency team arrived and transported to local hospital.
Paralysis all muscles for 5 months now, severe hypotonia. Hospitalized.
Was at work on 1/26/21 and collapsed, no known complaints a the time.   CRP was initiated immediately, transported to ER and  pronounced dead
cold feet; dizzy at times; sore arm; cold chills; fever of 103 for 3 days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (cold feet), DIZZINESS (dizzy at times), PAIN IN EXTREMITY (sore arm), CHILLS (cold chills) and PYREXIA (fever of 103 for 3 days after the vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included HIV disease and Heart attack.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (cold feet), DIZZINESS (dizzy at times), PAIN IN EXTREMITY (sore arm), CHILLS (cold chills) and PYREXIA (fever of 103 for 3 days after the vaccine). At the time of the report, PERIPHERAL COLDNESS (cold feet), DIZZINESS (dizzy at times), PAIN IN EXTREMITY (sore arm), CHILLS (cold chills) and PYREXIA (fever of 103 for 3 days after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not reported. Treatment information as not reported.   Reporter did not allow further contact
Irregular vaginal bleeding & menstrual type cramps. Started approximately 48 hours after receiving vaccine. Has continued on & off since receiving vaccine, usually lasting 1-2 days, then stopping for 2-4 days.
I have Fibromyalgia and Fibromyalgia hadn?t bothered me that bad for some time.  But now Fibromyalgia has flared up so bad.  Is it possible that the vaccine may have contributed to this flare up?  I?m in terrific pain now.
Terrible Deltoid, front of shoulder and arm pain shooting down upper arm and sometimes to wrist or weakness in fingers. Cannot lift arm or sweep the floor. Any kind of lifting causes severe pain. Cannot dress myself or put a bra on without setting off a terrible throbbing in my arm. I was ordered not to drive for 3 weeks.
Caller also noted that she had "a terrible response to the initial vaccine; This is a spontaneous report received from a contactable reporter (Nurse) from medical information team. The reporter is the patient.  A 43 year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "Caller also noted that she had "a terrible response to the initial vaccine". Additional information: Report no related to a study or program.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Small (less than one centimeter in diameter) bumps filled with clear liquid on skin. Slight red tint around bump.  Two on top of right ankle, two on right big toe, 4 in a line on left wrist, one on back of right thigh
pt recv vax 19JUL96 & 23JUL96 pt devel a red rash as big as a baseball & small fluid filled blisters in the same area as the inj;pt had no other ill sx & recovered;
sore arm; mild typical symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and VACCINATION COMPLICATION (mild typical symptoms) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION COMPLICATION (mild typical symptoms). On 23-Apr-2021, PAIN IN EXTREMITY (sore arm) and VACCINATION COMPLICATION (mild typical symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment medications were not provided.   This case was linked to MOD-2021-436428, MOD-2021-436438 (Patient Link).
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination. No Medical History information was reported. On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered). On 10-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired dose administered) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment information was provided. On 06-dec-2022 the vials placed in refrigerator. This case was linked to MOD-2022-448109 (Patient Link).
4/8 Thursday -chills and fever after almost 7 hours of injection and throughout the night -fever ranging from 100 -101 degrees -anxiousness, hallucinating likened to severe food poisoning, irrational behavior, inconsolable 4/9 Friday -confused and in malaise, could not work -low grade temp 99.9 -swelling underarm of vaxed arm 4/10 Better; still swelling under arm and skin sensitivity to touch and hot water,  like a numbness 4/11 Better but recurrence of fever 99.2 highest; still swelling under arm 4/12 Better; no fever, swelling but less under arm
Varicella Information has been received from a health professional concerning her daughter a 5 year old female who on 14-JUN-2002 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On -5-OCT-2005 the patient developed a mild case of breakthrough. The symptoms began with a temperature of 100.1F on 05-OCT-2005 and 10 lesions that appeared on 06-OCT-2005. At the time of the report the patient had not yet recovered. Unspecified medical attention was south. There was no product quality complaint involved. Additional information has been requested. Body temp 10/05/05 100.1F
Patient has general malaise  unknown cause . Onsite EMS was called vitals BP 168/78  99% O2 room air  HR 80 Patient Treated, Transported by the EMS to the hospital.
This case was reported by a physician and described the occurrence of injection site pain in an adult subject of unspecified gender who was vaccinated with BOOSTRIX (GlaxoSmithKline). On an unspecified date the subject received a dose of BOOSTRIX (unknown details). Forty-eight hours after vaccination with BOOSTRIX, the subject experienced injection site pain. At the time of reporting the event was resolved. The physician stated that the injection site pain "spontaneously resolved 24 hours later (72 hours after injection)." The lot number was reported as AC528103AA; however, based on lot number characterization, this lot number is incorrect and the correct lot number will be verified. This physician reported three cases of adverse events with BOOSTRIX. See cases A1010985A and A1010986A for details on the other cases. Follow up received from Vaccine Safety on 8 March 2013. The lot number reported was AC528103AA from the reporter; however, based on a safety lot number review, the lot number was updated to AC52B103AA.
Lower extremity muscle cramping (not near the site of injection) approximately 18 hours post-vaccination.
This spontaneous report as received from   a consumer refers to her daughter, a 10 year old female patient with no drug reactions/allergies. On an unknown date a few years ago, the patient was vaccinated with first dose of PNEUMOVAX23 (lot#, expiration date, dose, route, indication not reported). PNEUMOVAX23 (lot#, expiration date, dose, route, indication not reported). PNUEMOVAX23 was prescribed to the patient's unspecified coexisting "severe lung condition". The patient had no adverse experience from her initial dose of PNEUMOVAX23 or from unspecified previous flue shots (manufacturer unknown) which were administered on unspecified previous dates. On 05-NOV-2013 the patient was vaccinated with second dose of PNEUMOVAX23 (lot #, expiration date, dose, indication not reported, "injection" on the arm) and a dose of influenza virus vaccine (manufacturer unknown) (lot#, expiration date, dose, route, indication not reported on the other arm). Concomitant therapies included ADVAIR, FLOVENT, and NASONEX. On approximately 05-NOV-2013 ("about 36 hours after PNEUMOVAX23 injection on 06-NOV-2013" the patient experienced fever of 101-102 degrees Fahrenheit and, at the PNEUMOVAX23 injection site, a red circle which "measures about 2 inches in diameter". The patient had sought medical attention by speaking with an unspecified physician. No lab test was done. The patient was treated with ibuprofen for her fever, which was reported to "temporarily reduce the fever", but the fever had "always returned when the ibuprofen wore off" and at the time of the report, the patient was still experiencing both fever and the injection site redness. Additional information is not expected.
About a week after the second dose: Increased volume of Tinnitus in both left and right ears. Sometimes twice the volume and unbearably distracting and exhausting
Swelling observed on the neck on the same side as the vaccinated arm; Swollen in my neck like lymph node; I feel tight; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received bnt162b2 (PFIZER COVID 19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 15:30 (Lot number: ER8733) as single dose for covid-19 immunisation at the age of 48-year-old. The patient was not pregnant at vaccination. There were no medical history and concomitant medication. No allergy to medications, food, or other products. The patient was not diagnosed with COVID 19 prior to vaccination and hasn't been tested for COVID 19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swelling observed on the neck on the same side as the vaccinated arm on 17Apr2021 with outcome of not recovered and no treatment received for the event. The event was reported as non-serious. It was further reported as "I had a vaccine on 06Apr, so now I felt in the left hand that, swollen in my neck like lymph node. Is it related to the vaccine because I feel tight?". The event "I feel tight" was stated in Apr2021 with outcome of unknown. The event swollen in my neck like lymph node was started on 17Apr2021 with outcome of not recovered and no treatment received for the event.  No follow-up attempts are needed. No further information is expected.
Pt thinks he is having reaction to Tdap vaccine, nausea, no sleep, auditory problems. I advised pt to have someone drive him here.   HPI: Patient is brought in by his father. We have permission to talk to him. I was unable to talk to patient. I came in the room and he was wearing ear muffs. He was communicating by writing on his smart phone pad/paper. He wrote down "I have a anechoic tumor". He wrote down that any noise goes to the nerves in his teeth. When he called earlier this morning he said he had some nausea, regurgitation and could not sleep. He denied fever vomiting or redness at the site of injection or rash. I had to interview his dad in a different room because he could not tolerate me talking at all. Father says that he has not seen any reaction or rash on his body. Father is unaware that he has a diagnosis of tumor in his brain. Father agrees with me that something is wrong mentally with him today. He has a history of depression treated with ECT in the past but no history of schizophrenia or bipolar disorder as far as I know. After talking to his dad I went back to the room. Could not communicate verbally with him but was able to give him a written note saying that he needs to go to ER. Father wants to take him to the ER.
Pt had swelling at the site of PCV7 injection of 5cm X 6.5cm, 48 hours, post vax.
None reported Narrative: A 69yo male with history of Arthritis, Joint pain (ankle and foot), Hyperlipidemia, Hypertension and Allergic Rhinitis Per nursing immunization note- received Covid- 19 vaccine on February 6, 2021 and the second shot on February 27, 2021 per Policy and protocol, without any complication. He was also advised to stay on facility for 15 minutes post vaccination, was provided information on side effects and how to report ADR
Patient felt dizzy post vaccine, extra rest time and patient felt better, VS were taken and they were WNL
Information has been received from a licensed practical nurse referring to an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On 09-SEP-2015, the patients were inadvertently vaccinated with improperly stored doses of VAQTA (lot# L018499, expiration date 25-FEB-2017, strength, dose and route unknown). No adverse events had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Smothering pain around the injection site. Headache and drowsiness. Chills and pain everywhere
Developed mild case of rhabdomyolysis with Creatine levels of  2,877 U/L.  Treatment consisted of  two rounds of normal saline I.V. hydration. On May 20th and 21st once Liter  of saline each day for an hour. Labs (CK, CBC, CMP) were done on May 17th, May 20th and June 24th. It took about 2 months to achieve normal labs recordings.
Pt received vaccines on 9/14/00 and on 9/17/00 a red rash started with a low-grade temperature on 9/18/00. Arrived in ER and temperature was 102.2F and a rapid progressive rash starting on legs and rapidly changed to purpura and spreading to trunk. Rash was maculo-papular; confluent on legs and non-blanching, consistent with vasculitis, ? Henoch-Schonlein Purpura; no joint or abdominal pain.
dizziness (vertigo), felt the mattress moved, elevated as if it was going to turn to the right and had slight sweating.; dizziness (vertigo), felt the mattress moved, elevated as if it was going to turn to the right and had slight sweating.; my eyes went crossed-eyes momentarily; lump between my buttocks.; Had mild sinus.; mild throat and nose congestion pressure; Could taste medication in the mouth; soar left arm.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 29Mar2021 at 10:45(at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 11:00 the patient experienced mild throat and nose congestion pressure, could taste medication in the mouth and sore left arm. On 30Mar2021 at 08:00 the patient experienced lump between her buttocks and had mild sinus. On 30Mar2021 at 22:30 the patient experienced her eyes went crossed-eyes momentarily. On 31Mar2021 at 08:45 the patient experienced dizziness (vertigo), felt the mattress moved, elevated as if it was going to turn to the right and had slight sweating. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event mild throat and nose congestion pressure, Could taste medication in the mouth, sore left arm, lump between my buttocks, mild sinus, eyes went crossed-eyes momentarily, dizziness (vertigo), slight sweating was recovered with sequelae.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Resident received the 1st dose of the Moderna vaccine on 05 Feb 2021. She got the second dose today.; A spontaneous report was received from a nurse concerning an 83-years-old, female patient who experienced inappropriate schedule of product administration (resident received the 1st dose of the Moderna vaccine on 05 Feb 2021. She got the second dose today.)    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     The patient received their first of two planned doses of mRNA-1273 [Lot number 010M20A] on 05 Feb 2021.  On 11 Feb 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 [Lot number 030M230A] intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 11 Feb2021, the patient received her 2nd dose only six days after her first dose was administered. She reports no side effects from the 1st dose. Treatment information was not provided.   The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The event resident received the 1st dose of the Moderna vaccine on 05 Feb 2021. She got the second dose today was considered recovered/resolved on 11 Feb 2021.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #030M230A for second dose) with no associated AEs reported. Patient received second dose six days after the first dose.
Her lungs did the same thing where they had closed; Her lungs did the same thing where they had closed/her nose did the same thing where it closed as well/only it was a lot worse with her lungs and her nose; her nose did the same thing where it closed as well; She was breathing through her mouth because she couldn't breathe through her nose.; She had sat up for 4 nights trying to sleep.; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8733) via an unspecified route of administration into left arm on 30Mar2021 (at the age of 67-year-old) in the morning as single dose for COVID-19 immunisation. The patient's medical history were not reported. There were no concomitant medications. Historical vaccines include: INFLUENZA VACCINE on an unspecified date for immunization where she got sick for a week and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6199) into left arm on 09Mar2021 08:30 AM  (at the age of 67-year-old) for COVID-19 immunization and feeling like her lungs were starting to close up and her nose closed up completely, hard time breathing when doing anything that was exerting herself, she still had a hard time with her breathing and short of breath. It was reported that patient got her second dose on 30Mar2021 in the morning and on 31Mar2021 almost the same thing pretty much happened as the first one, only it was a lot worse with her lungs and her nose. Her lungs did the same thing where they had closed and her nose did the same thing where it closed as well. She already had everything ready to use for nebulizing and that opened her lungs but it didn't open her nose. It was further reported that since 31Mar2021 she had sat up for 4 nights trying to sleep and she was breathing through her mouth because she couldn't breathe through her nose. The patient went to her doctor's clinic where she was given treatment for the events reported; she was put on a heavier nebulizer; that kind of opened up her lungs and her nose and then her doctor also put her on prednisone. Outcome of events "she was breathing through her mouth because she couldn't breathe through her nose" and "she had sat up for 4 nights trying to sleep" was unknown while for all other events was recovering.